Onxeo S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,466.70
22,080.50
3,481.00
4,423.00
9,505.00
6,127
Cost of Goods Sold (COGS) incl. D&A
16,531.30
21,899.50
2,346.00
2,220.00
8,194.00
4,225
Gross Income
15,064.60
181.00
1,135.00
2,203.00
1,311.00
1,902
SG&A Expense
-
-
22,891.00
24,413.00
23,876.00
13,316
EBIT
-
616.10
22,176.00
23,169.00
22,875.00
5,981
Unusual Expense
-
-
-
-
47,188.00
11,418
Non Operating Income/Expense
127.10
1,782.70
611.00
1,520.00
328.00
368
Interest Expense
282.70
3,162.50
407.00
414.00
176.00
1,037
Pretax Income
15,296.10
5,471.40
21,734.00
22,063.00
70,554.00
18,789
Income Tax
-
2,149.80
2,354.00
565.00
11,483.00
4,214
Equity in Affiliates
28.60
77.40
29.00
43.00
-
5,176
Consolidated Net Income
15,324.60
7,698.60
19,409.00
22,671.00
59,071.00
9,399
Net Income
15,324.60
7,698.60
19,409.00
22,671.00
59,071.00
9,399
Net Income After Extraordinaries
15,324.60
7,698.60
19,409.00
22,671.00
59,071.00
9,399
Net Income Available to Common
15,324.60
7,698.60
19,409.00
22,671.00
59,071.00
9,399
EPS (Basic)
0.71
0.19
0.48
0.48
1.17
0.18
Basic Shares Outstanding
21,669.40
40,523.30
40,507.40
47,010.50
50,613.00
53,265.30
EPS (Diluted)
0.71
0.19
0.48
0.48
1.17
0.18
Diluted Shares Outstanding
21,683.80
40,544.20
40,544.20
47,010.50
50,613.00
53,265.30
EBITDA
15,188.60
355.50
20,357.00
21,305.00
21,001.00
5,393
Other Operating Expense
357.00
797.10
420.00
959.00
310.00
5,433
Non-Operating Interest Income
281.20
89.90
238.00
-
13.00
15
About Onxeo
View Profile
